심혈관 기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Cardiovascular Devices Market size is expected to reach USD 151.86 Billion in 2034 from USD 75.28 Billion (2025) growing at a CAGR of 8.11% during 2026-2034.

The Global Cardiovascular Devices Market is experiencing robust growth due to rising prevalence of heart diseases and increasing healthcare expenditure worldwide. Cardiovascular devices, including stents, pacemakers, and diagnostic equipment, are essential in managing coronary artery disease, arrhythmias, and other heart conditions. Growing aging populations and sedentary lifestyles are contributing significantly to market demand.

Key growth drivers include technological advancements in minimally invasive procedures and implantable devices. Expansion of catheter-based interventions and improved imaging technologies are enhancing treatment outcomes. Additionally, growing awareness about preventive cardiac care and early diagnosis is supporting increased device utilization across healthcare systems.

Looking ahead, the market is expected to benefit from innovation in bioresorbable stents, wearable cardiac monitoring devices, and AI-assisted diagnostics. Expanding healthcare infrastructure in emerging economies will provide new growth avenues. Continuous research and development efforts aimed at improving device safety and longevity will likely sustain strong global market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Diagnostic and Monitoring Devices
• Therapeutic and Surgical Devices

By Application

• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

By End User

• Hospitals
• Specialty Clinics
• Others

COMPANIES PROFILED

• B Braun Melsungen AG, Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson Johnson Services Inc, General Electric Company GE Healthcare, LivaNova PLC, Siemens Healthcare GmbH, Terumo Cardiovascular Systems Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Diagnostic and Monitoring Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutic and Surgical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Coronary Artery Disease (CAD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac Arrhythmia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIOVASCULAR DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 B. Braun Melsungen AG
  • 9.2.2 Medtronic
  • 9.2.3 Abbott
  • 9.2.4 Boston Scientific Corporation
  • 9.2.5 Edwards Lifesciences Corporation
  • 9.2.6 Johnson & Johnson Services Inc
  • 9.2.7 General Electric Company (GE Healthcare)
  • 9.2.8 LivaNova PLC
  • 9.2.9 Siemens Healthcare GmbH
  • 9.2.10 Terumo Cardiovascular Systems Corporation